groups of the Patient Concerns Inventory (PCI) trial. The baseline PCI data will also be described.
Methods This is a pragmatic cluster preference randomised control trial with 15 consultant clusters from two sites either
‘using’ (n = 8) or ‘not using’ (n = 7) the PCI at a clinic for all of their trial patients. The PCI is a 56-item prompt list that helps
patients raise concerns that otherwise might be missed. Eligibility was head and neck cancer patients treated with curative
intent (all sites, stage of disease, treatments).
Results From 511 patients first identified as eligible when screening for the multi-disciplinary tumour board meetings, 288
attended a first routine outpatient baseline study clinic after completion of their treatment, median (IQR) of 103 (71–162)
days. At baseline, the two trial groups were similar in demographic and clinical characteristics as well as in HRQOL measures
apart from differences in tumour location, tumour staging and mode of treatment. These exceptions were cluster (consultant)
related to Maxillofacial and ENT consultants seeing different types of cases. Consultation times were similar, with PCI
group times taking about 1 min longer on average (95% CL for the difference between means was from − 0.7 to + 2.2 min).
Conclusion Using the PCI in routine post-treatment head and neck cancer clinics do not elongate consultations. Recruitment
has finished but 12-month follow-up is still ongoing.
- Cluster preference
- Head and neck cancer
- Health-related quality of life
- Patient concerns inventory
- Prompt list
- Randomised trial